✦ LIBER ✦

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy

✍ Scribed by Leonardo Cocito; Maura Maffini; Carlo Loeb

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 373 KB
Volume: 19
Category: Article
ISSN: 0920-1211
DOI: 10.1016/0920-1211(94)90022-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of drug eluting stents in patient

Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel

✍ Vincenzo Pasceri; Giuseppe Patti; Christian Pristipino; Francesco Pelliccia; Die 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations

Effect of interferon therapy on hepatoce

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis

✍ Kenji Ikeda; Satoshi Saitoh; Yasuji Arase; Kazuaki Chayama; Yoshiyuki Suzuki; Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 3 views

The activity of interferon (IFN) is not elucidated from the viewpoint of cancer prevention in chronic hepatitis C patients en masse. The hepatocellular carcinogenesis rate was analyzed statistically in 1,643 patients with chronic hepatitis C: 1,191 patients with IFN therapy and 452 without IFN thera

Observations on the doubling time of pro

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

✍ Hans-Peter Schmid; John E. McNeal; Thomas A. Stamey 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views